Browsing by Subject "mutant flt3"
Now showing items 1-1 of 1
-
Phase ib study of the flt3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia
(Springer Nature, 2012-04-27)This phase 1b trial investigated several doses and schedules of midostaurin in combination with daunorubicin and cytarabine induction and high-dose cytarabine post-remission therapy in newly diagnosed patients with acute ...